Related Experiment Video
Updated: Jun 20, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
[Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis]
Abstract:
Analysis of ubiquitination of EGF receptor carrying different mutations of C-terminal domain was done. The mutants differed both by the set of major autophosphorylation sites that determine the way of interaction with ubiquitin-ligase c-Cbl, and by the presence of lysine residues which can be possible acceptor sites for ubiquitin. It was found that the receptor lacking tyrosine kinase activity due to lysine for phenylalanine substitution at ATP-binding site of tyrosine kinase (TK) domain (K721) failed to be ubiquitinated as well as the receptor without all binding sites for c-Cbl (CD165), while dynamics and pattern of ubiquitination of other deletion mutants was significantly different. The mutant lacking Grb2 binding sites but able to bind c-Cbl directly (CD123) was minimally ubiquitinated and only at early stages upon EGF endocytosis stimulation. At the same time, the receptor possessing all binding sites for Cbl but lacking C-terminal domain of 63 aminoacid residues (CD63) which contains two autophosphorylation sites (Y1148 and 1173) and 4 lysines, was less ubiquitinated and had more low-ubiquitinated forms comparing to the WT one. However, these lysines are not acceptor sites for ubiquitin since the full-size receptor lacking like CD63 the same major autophosphorylation sites underwent ubiquitination similar to the deletion mutant. Thus, C-terminal region of the EGF receptor, being not a substrate for ubiquitination per se, is involved in its regulation. It was also found that ubiquitination pattern at fast endocytosis differed from those at slow one. In the first case the total level of EGFR decreased dramatically as a result of efficient lysosomal degradation. The level of receptor-associated c-Cbl was practically the same, while the total intracellular c-Cbl dropped. Treatment of cells with proteasomal inhibition MG132 blocked the loss of Cbl only partially. In the second case, total amount of both EGF receptor and c-Cbl did not notably change that suggested recycling pathway for receptors even despite them beeng ubiquitinated.
Insights
The C-terminal domain of the Epidermal Growth Factor Receptor (EGFR) regulates its ubiquitination, influencing endocytosis pathways. Mutations affecting tyrosine kinase activity or c-Cbl binding sites alter ubiquitination patterns and degradation rates.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The Epidermal Growth Factor Receptor (EGFR) is crucial for cell growth and is often dysregulated in cancer.
- Ubiquitination of EGFR by the c-Cbl ligase is a key mechanism for its degradation and regulation.
- The C-terminal domain of EGFR contains autophosphorylation sites and lysine residues involved in protein interactions and modifications.
Purpose of the Study:
- To investigate the role of the EGFR C-terminal domain in its ubiquitination.
- To determine how specific mutations in the EGFR C-terminal domain affect ubiquitination patterns and downstream signaling.
- To elucidate the differential ubiquitination and trafficking of EGFR during fast versus slow endocytosis.
Main Methods:
- Site-directed mutagenesis to create EGFR mutants with altered C-terminal domains.
- Analysis of EGFR ubiquitination levels using immunoprecipitation and Western blotting.
- Investigation of EGFR endocytosis and degradation pathways under different stimulation conditions.
- Use of proteasomal inhibitor MG132 to assess protein degradation.
Main Results:
- EGFR mutants lacking tyrosine kinase activity (K721) or c-Cbl binding sites (CD165) showed no ubiquitination.
- Mutants with altered autophosphorylation sites exhibited varied ubiquitination dynamics.
- The C-terminal domain regulates ubiquitination, though its lysine residues are not direct ubiquitin acceptors.
- Fast endocytosis led to EGFR degradation, while slow endocytosis suggested receptor recycling, even with ubiquitination.
Conclusions:
- The EGFR C-terminal domain plays a regulatory role in EGFR ubiquitination, independent of direct ubiquitination sites.
- Ubiquitination patterns of EGFR differ significantly between fast and slow endocytosis pathways.
- These findings highlight the complex regulation of EGFR signaling and degradation by its C-terminal modifications and endocytic route.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
The Early Endosome: Endocytosis of Transferrin
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
